Japanese company profile · 4401

ADEKA CORPORATION

English company name recorded in Japan's EDINET filer data.

Original Japanese company name: 株式会社ADEKA

Name follows the English name recorded in EDINET filer data. English company name source

FY2025 · fiscal year ended March 2026Latest filing date: 2026-06-15

What does this company do?

What does this company do?

In its FY2025 public filing, ADEKA CORPORATION reports Chemicals, Food Products, Life Sciences Business. The page shows business-level revenue and profit where the source disclosures support comparison.

ADEKA CORPORATION's largest reported business by revenue in FY2025 was Chemicals.

The business with the highest reported segment profit in FY2025 was Chemicals.

FY2025 · fiscal year ended March 2026 · View original filing ↗ The source document may be in Japanese.

Reported company-wide figures

Company revenue
¥416.56B ↗
FY2025 · fiscal year ended March 2026
Operating profit
¥41.61B ↗
FY2025 · fiscal year ended March 2026
Comparable margin
10.0% ↗
FY2025 · fiscal year ended March 2026

JGAAP · Consolidated company-wide

Company profile

Company profile

Identity

Securities code
4401
EDINET code
E00878
Corporate number
1011501009437
Listing status
Listed
Industry (EDINET filer classification)
Chemicals

Location and fiscal year

Headquarters
東京都荒川区 · As filed in Japanese
Fiscal year end
3month
Latest fiscal year
FY2025
Accounting standard
JGAAP
P16 data snapshot
2026-11-07

Company size

Employees (consolidated)
5,434 people (FY2025)
Employees (non-consolidated)
1,827 people (FY2025)
Capital stock
JPY 23.0 billion (FY2025)

Official information

Public information is organized and presented by P16. EDINET filer list (2026-11-07) Opens in a new tab · EDINET PDL 1.0 terms Opens in a new tab

Business structure

How does it make money?

Revenue leader and profit leader

Chemicals

FY2025 · fiscal year ended March 2026 · Business Sales Operating profit
BusinessSalesShare of company salesOperating profitMargin
Chemicals¥214.99B ↗51.6%51.6%Sales to external customers: ¥214.81B ↗¥26.35B ↗12.3%
Life Sciences Business¥111.82B ↗26.8%26.8%Sales to external customers: ¥111.8B ↗¥9.82B ↗8.8%
Food Products¥83.11B ↗19.9%19.9%Sales to external customers: ¥83B ↗¥4.36B ↗5.2%

All values are in Japanese yen (JPY). No currency conversion is applied. FY2025 · fiscal year ended March 2026. Revenue and profit are shown only where the filing and data support a comparison. “—” means a comparable amount was not disclosed. We compare sales to outside customers for each business and the company as a whole, using the same filing, fiscal year and scope. Reported business sales may include sales between businesses. We leave the share blank when the figures cannot be matched.

Company revenue

Company-wide trend

Company revenue

JGAAP · Consolidated
  1. FY202187.1¥363.03B
  2. FY202296.8¥403.34B
  3. FY202396.0¥399.77B
  4. FY202497.7¥407.14B
  5. FY2025100.0¥416.56B

Company operating profit

JGAAP · Consolidated
  1. FY202183.9¥34.93B
  2. FY202277.8¥32.37B
  3. FY202385.1¥35.43B
  4. FY202498.5¥41.01B
  5. FY2025100.0¥41.61B

Only reported years are shown. Missing years are left blank; accounting standards and scopes are kept in separate series.

Reported Sales by business over time

Reported Sales by business over time

Fiscal yearFY2021FY2022FY2023FY2024FY2025
Chemicals¥200.22B¥211.86B¥204.28B¥218.62B¥214.99B
Food Products¥73.38B¥82.62B¥84.34B¥82.68B¥83.11B
Life Sciences Business¥81.91B¥102.09B¥103.03B¥99.97B¥111.82B

All amounts are in Japanese yen (JPY). Each figure links to the original Japanese filing. Blank cells indicate no comparable figure was disclosed. Business figures may not add up to consolidated figures.

What is growing?

What is growing?

Business revenue growth

This describes a reported period; it is not a forecast.

What has changed?

What has changed?

A five-year business-mix comparison is not shown because the available filings do not provide five comparable years on the same basis.

Source

Company profile

These scores summarize company characteristics using public filings. Comparison groups vary by measure. Higher is not always better.

  • Growth45
    Peer-position scoreFY2025
  • Profitability73
    Peer-position scoreFY2025
  • Business concentration21
    Peer-position scoreFY2025
  • Business change54
    Peer-position scoreFY2021→FY2025
  • Cash generation45
    Peer-position scoreFY2025
  • Growth persistence43
    Peer-position scoreFY2021→FY2022, FY2022→FY2023, FY2023→FY2024, FY2024→FY2025

Next

Ask about this company

Source

Public filing

FY2025 · fiscal year ended March 2026

The source document may be in Japanese.

Filing ID: S100YBCU

View original filing ↗

根拠となる資料